Browsing by Author "Firat A."

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Item
    Sexual dysfunction in female subjects with fibromyalgia
    (Lippincott Williams and Wilkins, 2005) Tikiz C.; Muezzinoglu T.; Pirildar T.; Taskin E.O.; Firat A.; Tuzun C.
    Purpose: We investigated sexual function in females with fibromyalgia (FM) and evaluate whether coexistent major depression (MD) has an additional negative effect on sexual function. Materials and Methods: A total of 100 female subjects were enrolled in the study, including 40 with FM only, 27 with FM plus MD and 33 healthy volunteers as a control group. The diagnosis of MD was made according to Structured Clinical Interview for Diagnostic and Statistical Manual-IV interview and the Hamilton Depression Rate Scale was used to grade depression. Widespread pain and quality of life were assessed with the Lattinen Pain Scale and Fibromyalgia Impact Questionnaire, respectively. The Female Sexual Function Index (FSFI) was used to assess sexual dysfunction. Results: All subjects were comparable in age, occupation and education. Mean FSFI total score ± SD was significantly decreased in the FM and FM plus MD groups compared with that in healthy controls (21.83 ± 5.84 and 22.43 ± 7.0 vs 28.10 ± 6.52, respectively, p = 0.001). However, the FSFI score was not significantly different between patients with FM only and FM plus MD (p >0.05). Correlation analysis revealed a negative moderate correlation between total Lattinen pain score and FSFI score in the FM only and FM plus MD groups (r = -0.366, p = 0.047 and r = -0.403, p = 0.018, respectively). FSFI score did not correlate with FIQ and HDRS scores (p >0.05). Conclusions: This study demonstrates that female patients with FM have distinct sexual dysfunction compared with healthy controls and coexistent MD has no additional negative effect on sexual function. Thus, female subjects with FM should be evaluated in terms of sexual function to provide better quality of life. Copyright © 2005 by American Urological Association.
  • No Thumbnail Available
    Item
    Transcutaneous electrical nerve stimulation therapy in the children with nocturnal enuresis; [Enüresis nokturnali çocuklarda transkütan elektri̇ksel si̇ni̇r sti̇mülasyonu (TENS) tedavi̇si̇]
    (Nobelmedicus, 2005) Ünlü Z.; Tüzün Ç.; Taneli C.; Firat A.
    We evaluated the efficacy of transcutaneous nerve stimulation (TENS) therapy on wetting behaviors, social functioning and bladder storage capacities in children with enuresis nocturna. A total of 8 enuretic children aged 8-16 years old were selected for study on basis of poor outcome despite extensive trials of conventional treatments. 15 seances of TENS therapy applied on the suprapubic region. Changes in wetting behaviors and social functioning before and after the therapy were assessed with a 7-point scale. Patients were asked to record their urine output using a frequency/volume chart for two consecutive days before and after the therapy. Two of the children became dry two months after the therapy. The total scores of wetting behaviors and social status were increased in two patients at two months after the therapy. Maximum functional bladder capacity, mean day-time bladder capacity, maximum nocturnal bladder capacity were increased only in two patients after the treatment. Number of daytime voids were decreased in these patients. According to our preliminary results, it seems that TENS therapy in the children with nocturnal enuresis showed improvement in some degree. Further studies are needed which are performed in larger series.
  • No Thumbnail Available
    Item
    Prevalence of depressive disorders among patients with fibromyalgia seeking help for the first time and its relationship with alexithymia; [Fizik tedavi ve rehabilitasyon polikliniǧine ilk kez başvuran ve fibromiyalji tanisi konan hastalarda depresif bozukluklarin görülme sikliǧi ve aleksitimi ile ilişkisi]
    (2007) Taşkin E.O.; Tikiz C.; Gürlek Yüksel E.; Firat A.; Tüzün Ç.; Aydemir Ö.
    Objective: In this study, it was aimed to determine the prevalence of depression and its relationship with alexithymia among patients with fibromyalgia who apply to the Physical Therapy and Rehabilitation outpatient clinic for the first time. Methods: The research included 50 patients who applied to the Physical Therapy and Rehabilitation outpatient clinic for the first time and diagnosed as FM according to the American College of Rheumatology Scale. The subjects were evaluated with the SCID-I affective disorders module, 20-item Toronto Alexithymia Scale (TAS-20), 17-item Hamilton Depression Scale (HAM-D) and a demographic data form. Data were analyzed using t-test for continuous numerical parameters and chi-square test for categorized parameters. Pearson correlation test was used for determination of correlation between HAM-D and TAS-20 scores. Results: The prevalence of major depressive episode, depressive disorder NOS and dysthymia were found to be 44%, 10% and 14% respectively. None of the patients were seeking help for their depressive disorder and were using antidepressant treatment. TAS-20 scores of the patients with depression were higher (p=0.022) than scores of the non-depressive patients. Alexithymic patients had higher HAM-D mean values (p=0.035) and there was a positive correlation between TAS-20 and HAM-D scores (p=0.014). Conclusion: In fibromyalgia, the prevalence rate of depression is found to be significant. The prevalence rate of depression was even higher in alexithymic patients. Patients with fibromyalgia seem to have difficulty in experiencing their depression, and thus they do not seek psychiatric help. Therefore, these patients must be evaluated additionally for depression during the management of fibromyalgia.